BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Debiopharm at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Debiopharm takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions ask where investors, pharma and biotech are placing their bets on the next oncology winners, and introduce Debiopharm to dealmakers in the Business of Biotech track. Debiopharm also sponsors the meeting.

OrganizationBIO-Europe 2026 Attendance
Debiopharm
Lausanne, Switzerland
◆Gold Sponsor
Large pharmaGold sponsor
Swiss privately owned biopharmaceutical group developing oncology and bacterial infection treatments.
Panel
Mon Nov 9
15:00–15:45
The next oncology winners: Where investors, pharma and biotech are placing their bets
Which cancer treatments, from radioactive targeted drugs to newer immunotherapies, now draw investors, and what makes a cancer biotech worth funding.
with Pullan Consulting, SRTD Biotech, Women in Life Science Denmark +1 more
Talk
Tue Nov 10
10:15–10:30
Pharma Presentation: Debiopharm International SA
How Debiopharm licenses in promising drugs for cancer and bacterial infections, tests them in trials, then picks large drug companies to sell them.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Debiopharm

Tell us what you sell and we’ll find the people at Debiopharm most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction